Improving arteriovenous fistula patency: Transdermal delivery of diclofenac reduces cannulation-dependent neointimal hyperplasia via AMPK activation

Creation of an autologous arteriovenous fistula (AVF) for vascular access in haemodialysis is the modality of choice. However neointimal hyperplasia and loss of the luminal compartment result in AVF patency rates of ~ 60% at 12 months. The exact cause of neointimal hyperplasia in the AVF is poorly u...

Descripción completa

Detalles Bibliográficos
Autores principales: MacAskill, Mark G., Watson, David G., Ewart, Marie-Ann, Wadsworth, Roger, Jackson, Andrew, Aitken, Emma, MacKenzie, Graeme, Kingsmore, David, Currie, Susan, Coats, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534710/
https://www.ncbi.nlm.nih.gov/pubmed/25866325
http://dx.doi.org/10.1016/j.vph.2015.02.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534710/
https://www.ncbi.nlm.nih.gov/pubmed/25866325
http://dx.doi.org/10.1016/j.vph.2015.02.012

Ejemplares similares